3 Results for "

Ltk cell

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "Ltk cell" in MCE Product Catalog:

Art. -Nr.: HY-155516
CAS. Nr.: 3052324-00-9
Reinheit:  98.34%
Target:  

Potassium Channel

Forschungsgebiete:  

Inflammation/Immunology

KV1.3-IN-1 (Compound trans-18) is a KV1.3 channel inhibitor (IC50: 230 nM and 26.12 nM in Ltk cells and PHA-activated T-lymphocytes respectively). KV1.3-IN-1 impairs intracellular Ca 2+ signaling. KV1.3-IN-1 inhibits T-cell activation, proliferation, and colony formation .
loading...
    loading...
Art. -Nr.: HY-171155
CAS. Nr.: 1360282-15-0
Target:  

Tyrosinase

Forschungsgebiete:  

Cancer

CLIP1-LTK fusion protein regulator-1 is a 7-azaindol-6-amine class CLIP1-LTK fusion protein regulator and CLIP1-LTK fusion protein receptor inhibitor. CLIP1-LTK fusion protein regulator-1 suppresses abnormal proliferation of CLIP1-LTK-dependent cells.CLIP1-LTK fusion protein regulator-1 can be used for the research of non-small cell lung cancer .
loading...
    loading...
Art. -Nr.: HY-12962A
CAS. Nr.: 1784252-90-9
Target:  

iGluR

Forschungsgebiete:  

Neurological Disease

NMDA-IN-1 dihydrochloride is a selective NMDA NR2B antagonist with a Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM. NMDA-IN-1 dihydrochloride inhibits Glu/Gly stimulated Ca2+ flux in Ltk- cells expressing the hNR1a/NR2B with a IC50 of 9.7 nM. NMDA-IN-1 dihydrochloride has no activities on NR2A, NR2C, NR2D, hERG-channel and α1-adrenergic receptor. NMDA-IN-1 dihydrochloride shows excellent activity in the mechanical hyperalgesia assay in rats. NMDA-IN-1 dihydrochloride can be used for the studies of stroke, parkinson, and neuropathic pain .
loading...
    loading...